Total Payments
$61,824
2024 Payments
$2,035
Companies
14
Transactions
118
Payment Breakdown by Category
Research$22,719 (36.7%)
Consulting$11,701 (18.9%)
Other$11,240 (18.2%)
Travel$10,906 (17.6%)
Food & Beverage$5,258 (8.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $22,719 | 18 | 36.7% |
| Consulting Fee | $11,701 | 5 | 18.9% |
| Travel and Lodging | $10,906 | 34 | 17.6% |
| Honoraria | $7,000 | 3 | 11.3% |
| Food and Beverage | $5,258 | 57 | 8.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,240 | 1 | 6.9% |
Payments by Type
General
$39,105
100 transactions
Research
$22,719
18 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Octapharma USA, Inc. | $31,072 | 43 | $0 (2022) |
| PFIZER INC. | $17,258 | 24 | $0 (2024) |
| Bioverativ Therapeutics Inc. | $4,309 | 3 | $0 (2017) |
| Bayer Healthcare Pharmaceuticals Inc. | $3,921 | 15 | $0 (2023) |
| BioMarin Pharmaceutical Inc. | $1,943 | 8 | $0 (2023) |
| Novo Nordisk AS | $1,564 | 4 | $0 (2019) |
| Genentech USA, Inc. | $548.01 | 4 | $0 (2023) |
| CSL Behring | $402.65 | 4 | $0 (2023) |
| Spark Therapeutics, Inc. | $226.21 | 3 | $0 (2022) |
| HEMA Biologics, LLC | $225.14 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,035 | 4 | PFIZER INC. ($1,880) |
| 2023 | $6,353 | 13 | PFIZER INC. ($5,740) |
| 2022 | $4,321 | 11 | PFIZER INC. ($3,630) |
| 2021 | $2,540 | 4 | PFIZER INC. ($2,540) |
| 2019 | $15,307 | 34 | Octapharma USA, Inc. ($9,430) |
| 2018 | $11,422 | 31 | Octapharma USA, Inc. ($6,070) |
| 2017 | $19,845 | 21 | Octapharma USA, Inc. ($15,490) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 09/26/2024 | GENZYME CORPORATION | ALTUVIIIO (Biological), ALPROLIX | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: Hematology | ||||||
| 03/28/2024 | PFIZER INC. | BENEFIX (Biological), BEQVEZ | — | In-kind items and services | $940.00 | Research |
| Study: BENEFIX CLINICAL PUBLICATION PROGRAM • Category: HEMATOLOGY | ||||||
| 03/27/2024 | PFIZER INC. | BENEFIX (Biological), BEQVEZ | — | In-kind items and services | $940.00 | Research |
| Study: BENEFIX CLINICAL PUBLICATION PROGRAM • Category: HEMATOLOGY | ||||||
| 12/15/2023 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: PF05280602 CLINICAL PUBLICATION PROGRAM | ||||||
| 12/11/2023 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $64.30 | General |
| Category: Hematology | ||||||
| 12/11/2023 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $64.30 | General |
| Category: Hematology | ||||||
| 12/10/2023 | PFIZER INC. | BENEFIX (Biological), XYNTHA | — | In-kind items and services | $940.00 | Research |
| Study: NONACOG ALFA PF05280602 PF05230907 MOROCTOCOG ALFA MULTI PRODUCT FIDANACOGENE ELAPARVOVEC GIROCTOCOGENE FITELPARVOVEC MARSTACIMAB CLINICAL PUBLICATION PROGRAM • Category: HEMATOLOGY | ||||||
| 12/09/2023 | CSL Behring | HEMGENIX (Biological) | Food and Beverage | In-kind items and services | $119.36 | General |
| Category: Hematology | ||||||
| 12/08/2023 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $176.55 | General |
| 08/01/2023 | PFIZER INC. | BENEFIX (Biological) | — | In-kind items and services | $330.00 | Research |
| Study: NONACOG ALFA CLINICAL PUBLICATION PROGRAM • Category: HEMATOLOGY | ||||||
| 06/16/2023 | PFIZER INC. | — | — | In-kind items and services | $3,200.00 | Research |
| Study: FIDANACOGENE ELAPARVOVEC CLINICAL PUBLICATION PROGRAM | ||||||
| 06/14/2023 | Bayer Healthcare Pharmaceuticals Inc. | Jivi (Drug) | Food and Beverage | In-kind items and services | $44.73 | General |
| Category: Hematology | ||||||
| 03/24/2023 | Bayer Healthcare Pharmaceuticals Inc. | Jivi (Drug) | Food and Beverage | In-kind items and services | $46.82 | General |
| Category: Hematology | ||||||
| 03/22/2023 | GENZYME CORPORATION | ALTUVIIIO (Biological) | Food and Beverage | In-kind items and services | $36.32 | General |
| Category: Hematology | ||||||
| 02/08/2023 | PFIZER INC. | — | — | In-kind items and services | $940.00 | Research |
| Study: MOROCTOCOG ALFA CLINICAL PUBLICATION PROGRAM | ||||||
| 02/02/2023 | BioMarin Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $60.80 | General |
| 12/22/2022 | PFIZER INC. | XYNTHA (Biological), BENEFIX | — | In-kind items and services | $3,200.00 | Research |
| Study: HEMOPHILIA CLINICAL PUBLICATION PROGRAM • Category: HEMATOLOGY | ||||||
| 12/11/2022 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $63.91 | General |
| Category: Hematology | ||||||
| 12/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $120.98 | General |
| 12/09/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $147.99 | General |
| 10/26/2022 | PFIZER INC. | XYNTHA (Biological), BENEFIX | — | In-kind items and services | $330.00 | Research |
| Study: HEMOPHILIA CLINICAL PUBLICATION PROGRAM • Category: HEMATOLOGY | ||||||
| 09/26/2022 | Octapharma USA, Inc. | NUWIQ (Biological), WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) | Food and Beverage | In-kind items and services | $81.76 | General |
| Category: COAGULATION | ||||||
| 08/18/2022 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: Hematology | ||||||
| 08/16/2022 | CSL Behring | — | Food and Beverage | In-kind items and services | $112.42 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GENA-05 | Octapharma USA, Inc. | $9,029 | 5 |
| HEMOPHILIA CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $6,070 | 6 |
| FIDANACOGENE ELAPARVOVEC CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $3,200 | 1 |
| BENEFIX CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,880 | 2 |
| MOROCTOCOG ALFA CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $940.00 | 1 |
| NONACOG ALFA PF05280602 PF05230907 MOROCTOCOG ALFA MULTI PRODUCT FIDANACOGENE ELAPARVOVEC GIROCTOCOGENE FITELPARVOVEC MARSTACIMAB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $940.00 | 1 |
| NONACOG ALFA CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $330.00 | 1 |
| PF05280602 CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $330.00 | 1 |
About Jonathan Ducore, MD, MPH
Jonathan Ducore, MD, MPH is a Pediatric Hematology-Oncology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124001417.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Ducore, MD, MPH has received a total of $61,824 in payments from pharmaceutical and medical device companies, with $2,035 received in 2024. These payments were reported across 118 transactions from 14 companies. The most common payment nature is "" ($22,719).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Sacramento, CA
- Active Since 11/21/2005
- Last Updated 08/24/2007
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1124001417
Products in Payments
- NUWIQ (Biological) $22,970
- WILATE (Biological) $7,989
- XYNTHA (Biological) $3,530
- Non-Covered $3,253
- BENEFIX (Biological) $3,150
- Jivi (Drug) $546.66
- SevenFact (Biological) $225.14
- HEMLIBRA (Biological) $223.47
- HEMGENIX (Biological) $119.36
- OCTAGENATE (Biological) $112.59
- ALTUVIIIO (Biological) $66.53
- Alprolix (Drug) $46.61
- Afstyla (Biological) $45.87
- FITUSIRAN (Drug) $28.09
- Eloctate (Drug) $22.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Sacramento
Dr. Arun Panigrahi, M.d, M.D
Pediatric Hematology-Oncology — Payments: $123,055
Pediatric Hematology-Oncology $123,055
Ms. Anjali Pawar, M.d, M.D
Pediatric Hematology-Oncology — Payments: $59,752
Pediatric Hematology-Oncology $59,752
Dr. Saunders Hsu, Md, MD
Pediatric Hematology-Oncology — Payments: $3,642
Pediatric Hematology-Oncology $3,642
Mr. Yung Yim, Md, MD
Pediatric Hematology-Oncology — Payments: $3,541
Pediatric Hematology-Oncology $3,541
Dr. Yisheng Lee, Md, MD
Pediatric Hematology-Oncology — Payments: $2,290
Pediatric Hematology-Oncology $2,290
Noriko Satake, Md, MD
Pediatric Hematology-Oncology — Payments: $521.65
Pediatric Hematology-Oncology $521.65